Information:
Error:
ID
30084
Description
A Study of RoActemra/Actemra (Tocilizumab) in Patients With Active Systemic Juvenile Idiopathic Arthritis (JIA); ODM derived from: https://clinicaltrials.gov/show/NCT00642460
Link
https://clinicaltrials.gov/show/NCT00642460
Keywords
Versions (1)
- 5/9/18 5/9/18 -
Copyright Holder
See clinicaltrials.gov
Uploaded on
May 9, 2018
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Juvenile Idiopathic Arthritis NCT00642460
Eligibility Juvenile Idiopathic Arthritis NCT00642460
- StudyEvent: Eligibility
Similar models
Eligibility Juvenile Idiopathic Arthritis NCT00642460
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Age
Item
patients aged 2-17 years of age
boolean
C0001779 (UMLS CUI [1])
Juvenile arthritis Disease length
Item
systemic juvenile idiopathic arthritis with >= 6 months persistent activity
boolean
C3495559 (UMLS CUI [1,1])
C0872146 (UMLS CUI [1,2])
C0872146 (UMLS CUI [1,2])
Disease Active | Active joint count | Fever
Item
presence of active disease (>=5 active joints, or >=2 active joints + fever +
boolean
C0012634 (UMLS CUI [1,1])
C0205177 (UMLS CUI [1,2])
C4067216 (UMLS CUI [2])
C0015967 (UMLS CUI [3])
C0205177 (UMLS CUI [1,2])
C4067216 (UMLS CUI [2])
C0015967 (UMLS CUI [3])
Steroids
Item
steroids)
boolean
C0038317 (UMLS CUI [1])
NSAIDs Response Inadequate | Adrenal Cortex Hormones Response Inadequate | Etiology Toxicity | Etiology Lack of Efficacy
Item
inadequate clinical response to nonsteroidal anti-inflammatory drugs (nsaids) and corticosteroids due to toxicity or lack of efficacy
boolean
C0003211 (UMLS CUI [1,1])
C1704632 (UMLS CUI [1,2])
C0205412 (UMLS CUI [1,3])
C0001617 (UMLS CUI [2,1])
C1704632 (UMLS CUI [2,2])
C0205412 (UMLS CUI [2,3])
C0015127 (UMLS CUI [3,1])
C0600688 (UMLS CUI [3,2])
C0015127 (UMLS CUI [4,1])
C0235828 (UMLS CUI [4,2])
C1704632 (UMLS CUI [1,2])
C0205412 (UMLS CUI [1,3])
C0001617 (UMLS CUI [2,1])
C1704632 (UMLS CUI [2,2])
C0205412 (UMLS CUI [2,3])
C0015127 (UMLS CUI [3,1])
C0600688 (UMLS CUI [3,2])
C0015127 (UMLS CUI [4,1])
C0235828 (UMLS CUI [4,2])
Wheelchair bound | Bed-ridden
Item
wheelchair-bound or bed-ridden
boolean
C0558195 (UMLS CUI [1])
C0425251 (UMLS CUI [2])
C0425251 (UMLS CUI [2])
Autoimmune Diseases | Rheumatism | Overlap syndrome | Exception Juvenile arthritis
Item
any other autoimmune, rheumatic disease or overlap syndrome other than systemic juvenile idiopathic arthritis
boolean
C0004364 (UMLS CUI [1])
C0035435 (UMLS CUI [2])
C0410000 (UMLS CUI [3])
C1705847 (UMLS CUI [4,1])
C3495559 (UMLS CUI [4,2])
C0035435 (UMLS CUI [2])
C0410000 (UMLS CUI [3])
C1705847 (UMLS CUI [4,1])
C3495559 (UMLS CUI [4,2])
Adrenal Cortex Hormones Intravenous Active Long-term | Adrenal Cortex Hormones Intraarticular
Item
intravenous long-acting corticosteroids or intra-articular corticosteroids within 4 weeks of baseline, or throughout study
boolean
C0001617 (UMLS CUI [1,1])
C1522726 (UMLS CUI [1,2])
C0205177 (UMLS CUI [1,3])
C0443252 (UMLS CUI [1,4])
C0001617 (UMLS CUI [2,1])
C1522204 (UMLS CUI [2,2])
C1522726 (UMLS CUI [1,2])
C0205177 (UMLS CUI [1,3])
C0443252 (UMLS CUI [1,4])
C0001617 (UMLS CUI [2,1])
C1522204 (UMLS CUI [2,2])
Antirheumatic Drugs, Disease-Modifying | Exception Methotrexate
Item
disease-modifying antirheumatic drugs (dmards), other than methotrexate
boolean
C0242708 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0025677 (UMLS CUI [2,2])
C1705847 (UMLS CUI [2,1])
C0025677 (UMLS CUI [2,2])
tocilizumab
Item
previous treatment with tocilizumab
boolean
C1609165 (UMLS CUI [1])